cinclus pharma header news

Media

Media

News and press releases

Welcome to our media section. Check out the latest news and press releases from Cinclus Pharma and don’t hesitate to contact us if you need more information. 

Media gallery

Cinclus Pharma Charlotte

Charlotte Stjerngren

Press and IR

E-mail: Send e-mail

E-mail: Send e-mail

Phone: +46 708 768 787

Latest pressreleases


See allSubscribe

Latest News


Cinclus Redeye Growth Day 03

Presentation of the company and the development of linaprazan glurate from Redeye Transactions

Here you can watch the full presentation (in Swedish) of Cinclus Pharma and the development of linaprazan glurate, held by CEO Christer Ahlberg at Redeye Transactions June 13th.

Cinclus News Christer Finansieringsevent 02

Presentation of the company and the development of linaprazan glurate from Aktiespararnas event June 12th

Here you can watch the full presentation (in Swedish) of Cinclus Pharma and the development of linaprazan glurate, held by CEO Christer Ahlberg at Aktiespararnas event June 12th.

Cinclus News Image Notering

Cinclus Pharma announces listing on Nasdaq Stockholm and offering of ordinary shares as well as publishes related prospectus

Cinclus Pharma Holding AB (publ) (“Cinclus Pharma” or the “Company”), a Swedish clinical stage pharmaceutical company, has resolved to diversify the shareholder base through an offering of newly issued ordinary shares (the “Offering”) and has at the…

Cinclus Redeye Growth Day 02

Presentation of the company and the development of linaprazan glurate from Redeye Growth Day 2024.

Here you can watch the full presentation (in Swedish) of CInclus Pharma and the development of linaprazan glurate, held by CEO Christer Ahlberg at Redeye Growth Day 2024.